ABSTRACT Lysosome‐targeting chimeras (LYTACs) have emerged as a strategy for eliminating secreted, extracellular, and plasma‐membrane proteins by redirecting them to the endolysosomal system. By coupling target recognition to receptor‐mediated uptake, LYTACs exploit endogenous trafficking pathways to access disease‐ass...
Ke Liu, Xi-Yan Wang, Xiao-Zhen Liu et al.· Advancement of science· 0 citations
ABSTRACT Targeted degradation of membrane proteins via the lysosomal pathway holds great therapeutic promise, yet existing platforms rely on bulky ligands such as glycopolymers, antibodies, or protein nanocages, which complicate synthesis and limit tissue penetration. Here, we repurpose L‑type amino acid transporter 1...
Li-Quan Zhu, Ke Liu, Hao-Tian Liu et al.· Advancement of science· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.